...
首页> 外文期刊>International Journal of Research in Medical Sciences >Prevalence of hepatitis B and C among patients admitted in respiratory medicine ward of a tertiary care hospital in Mullana, Ambala, Haryana, India
【24h】

Prevalence of hepatitis B and C among patients admitted in respiratory medicine ward of a tertiary care hospital in Mullana, Ambala, Haryana, India

机译:在穆拉纳,Ambala,哈里亚纳,印度近期护理医院呼吸系医院患者患者中患有乙型肝炎和C的患者

获取原文

摘要

Background: Viral Hepatitis B and C have become a major public health problem. Hepatitis B affects approximately 30% of world population or about 2 billion people have serological evidence of either current or past infection. Hepatitis C virus infects approximately 3% of world population placing about 170 million people at risk of liver disease. In India, HBsAg prevalence rates among general population ranges from 0.1% to 11.7%, being 2% to 8% in most studies and seroprevalence for Hepatitis C ranges from 0.1% to 8% among general population. Methods: The study was conducted in the respiratory medicine Ward, MMIMSR in the month of August 2016. 200 patients were taken up for the study after clinical examination, necessary investigation and proper consent. Patients were tested for HBsAg antigen and HCV Tridot. Patients were put through a carefully designed questionnaire to look for possible cause of infection. Patients who came out to be positive for either Hepatitis B or C were counselled about further investigations and treatment options. Results: The prevalence rate for Hepatitis B came out to be 9% and for Hepatitis C was 5.5%. Hepatitis has become a major public health issue in India particularly in the rural areas. High prevalence rates among patients with respiratory diseases can be attributed to unsafe therapeutic injections and use of shared needles. Conclusions: There is a need to carry out larger studies to better elucidate the epidemiology of Hepatitis B and C and to identify high prevalence areas and simultaneously focus on improving public health measures to prevent disease transmission and decrease the burden of disease.
机译:背景:病毒性乙型肝炎和C已成为一个主要的公共卫生问题。乙型肝炎影响世界人口的约30%或约20亿人有当前或过去感染的血清学证据。丙型肝炎病毒在肝脏疾病风险中感染了大约1.7亿人口的世界人口的3%。在印度,一般人群的HBsAg流行率从0.1%到11.7%,在大多数研究中,丙型肝炎的血清额落率为2%至8%,普遍存产中的0.1%至8%。方法:该研究在呼吸系统病房中进行,MMIMSR在2016年8月。临床检查后的200名患者进行研究,进行了必要的调查和适当的同意。测试患者HBsAg抗原和HCV Tridot。患者通过精心设计的问卷来寻找可能的感染原因。出现乙型肝炎或C阳性的患者是关于进一步调查和治疗方案的咨询。结果:乙型肝炎的患病率为9%,对于丙型肝炎为5.5%。肝炎已成为印度的主要公共卫生问题,特别是在农村地区。呼吸系统疾病患者的高流行率可归因于不安全的治疗注射和使用共用针。结论:需要进行更大的研究,以更好地阐明乙型肝炎和C的流行病学,并识别高流行区域,并同时关注改善公共卫生措施,以防止疾病传播并降低疾病负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号